|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-2-5
|
|
pubmed:abstractText |
The pharmacodynamic properties of a new angiotensin II receptor antagonist (BAY 10-6734) in humans were to be quantitatively characterized from the rightward shifts of the agonist dose-response curves after administration of different doses of the antagonist.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0946-1965
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
434-41
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9352392-Administration, Oral,
pubmed-meshheading:9352392-Adult,
pubmed-meshheading:9352392-Angiotensin II,
pubmed-meshheading:9352392-Angiotensin Receptor Antagonists,
pubmed-meshheading:9352392-Blood Pressure,
pubmed-meshheading:9352392-Calcium Channel Blockers,
pubmed-meshheading:9352392-Dihydropyridines,
pubmed-meshheading:9352392-Dose-Response Relationship, Drug,
pubmed-meshheading:9352392-Heart Rate,
pubmed-meshheading:9352392-Humans,
pubmed-meshheading:9352392-Infusions, Intravenous,
pubmed-meshheading:9352392-Male,
pubmed-meshheading:9352392-Regression Analysis,
pubmed-meshheading:9352392-Tetrazoles,
pubmed-meshheading:9352392-Vasoconstrictor Agents
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
|
|
pubmed:affiliation |
Center of Cardiovascular Pharmacology, ZeKaPha GmbH, Mainz/Wiesbaden, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
